A citation-based method for searching scientific literature

Ava Kwong, Isabella Wy Cheuk, Vivian Yvonne Shin, Cecilia Ys Ho, Chun-Hang Au, Dona Ny Ho, Elaine Yl Wong, Stephanie Wy Yu, Jiawei Chen, Karen Kl Chan, Hextan Ys Ngan, Tsun-Leung Chan, Edmond Sk Ma. Am J Cancer Res 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
50

Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
50


Network based stratification of major cancers by integrating somatic mutation and gene expression data.
Zongzhen He, Junying Zhang, Xiguo Yuan, Zhaowen Liu, Baobao Liu, Shouheng Tuo, Yajun Liu. PLoS One 2017
6
50

SVM and SVM Ensembles in Breast Cancer Prediction.
Min-Wei Huang, Chih-Wen Chen, Wei-Chao Lin, Shih-Wen Ke, Chih-Fong Tsai. PLoS One 2017
40
50

Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.
Arvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, Rachel Doherty, Paul M Moseley, Mohammed A Aleskandarany, Andrew R Green, Graham Ball, Alaa T Alshareeda, Emad A Rakha,[...]. Mol Cancer Ther 2015
26
50


FANCD2 associated with sporadic breast cancer risk.
E Barroso, R L Milne, L P Fernández, P Zamora, J I Arias, J Benítez, G Ribas. Carcinogenesis 2006
28
50

An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.
Dan Xue, Pu Cheng, Mengjiao Han, Xiyong Liu, Lijun Xue, Chenyi Ye, Ke Wang, Jian Huang. Onco Targets Ther 2018
10
50


High expression of KIF26B in breast cancer associates with poor prognosis.
Qun Wang, Zong-Bin Zhao, Geng Wang, Zhen Hui, Ming-Hua Wang, Jun-Feng Pan, Hong Zheng. PLoS One 2013
28
50

ABCC9, NKAPL, and TMEM132C are potential diagnostic and prognostic markers in triple-negative breast cancer.
Xiaoyu Zhang, Xiaoning Kang, Lijun Jin, Jie Bai, Hui Zhang, Wei Liu, Zunyi Wang. Cell Biol Int 2020
3
50

Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.
Simon Kebede Merid, Daria Goranskaya, Andrey Alexeyenko. BMC Bioinformatics 2014
43
50


Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer.
Angela Ogden, Chakravarthy Garlapati, Xiaoxian Bill Li, Ravi Chakra Turaga, Gabriela Oprea-Ilies, Nikita Wright, Shristi Bhattarai, Karuna Mittal, Ceyda Sönmez Wetherilt, Uma Krishnamurti,[...]. Sci Rep 2017
11
50




Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Julia L Fleck, Ana B Pavel, Christos G Cassandras. BMC Syst Biol 2016
10
50

ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.
Ekaterina V Kalashnikova, Alexey S Revenko, Abigael T Gemo, Nicolas P Andrews, Clifford G Tepper, June X Zou, Robert D Cardiff, Alexander D Borowsky, Hong-Wu Chen. Cancer Res 2010
115
50

Replication of RYR3 gene polymorphism association with cIMT among HIV-infected whites.
Sadeep Shrestha, Qi Yan, Gregory Joseph, Donna K Arnett, Jeremy J Martinson, Lawrence A Kingsley. AIDS 2012
7
50

Systematic analysis of somatic mutations impacting gene expression in 12 tumour types.
Jiarui Ding, Melissa K McConechy, Hugo M Horlings, Gavin Ha, Fong Chun Chan, Tyler Funnell, Sarah C Mullaly, Jüri Reimand, Ali Bashashati, Gary D Bader,[...]. Nat Commun 2015
55
50


SMOTE for high-dimensional class-imbalanced data.
Rok Blagus, Lara Lusa. BMC Bioinformatics 2013
114
50


The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.
Katarzyna Tomczak, Patrycja Czerwińska, Maciej Wiznerowicz. Contemp Oncol (Pozn) 2015
50


Integrating Germline and Somatic Mutation Information for the Discovery of Biomarkers in Triple-Negative Breast Cancer.
Jiande Wu, Tarun Karthik Kumar Mamidi, Lu Zhang, Chindo Hicks. Int J Environ Res Public Health 2019
5
50


PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.
Steven Catchpole, Bradley Spencer-Dene, Debbie Hall, Samantha Santangelo, Ian Rosewell, Mounia Guenatri, Richard Beatson, Angelo G Scibetta, Joy M Burchell, Joyce Taylor-Papadimitriou. Int J Oncol 2011
101
50

Accumulation of driver and passenger mutations during tumor progression.
Ivana Bozic, Tibor Antal, Hisashi Ohtsuki, Hannah Carter, Dewey Kim, Sining Chen, Rachel Karchin, Kenneth W Kinzler, Bert Vogelstein, Martin A Nowak. Proc Natl Acad Sci U S A 2010
434
50

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
231
50

Exploratory undersampling for class-imbalance learning.
Xu-Ying Liu, Jianxin Wu, Zhi-Hua Zhou. IEEE Trans Syst Man Cybern B Cybern 2009
139
50

The Clinical Significance of PPEF1 as a Promising Biomarker and Its Potential Mechanism in Breast Cancer.
Ting Ye, Xue Wan, Jingyuan Li, Jia Feng, Jinglan Guo, Guangrong Li, Jinbo Liu. Onco Targets Ther 2020
2
50

A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.
Yuanyuan Li, Kai Kang, Juno M Krahn, Nicole Croutwater, Kevin Lee, David M Umbach, Leping Li. BMC Genomics 2017
50
50

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
197
50

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D Beitsch, Pat W Whitworth, Kevin Hughes, Rakesh Patel, Barry Rosen, Gia Compagnoni, Paul Baron, Rache Simmons, Linda Ann Smith, Ian Grady,[...]. J Clin Oncol 2019
110
50

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Mary B Daly, Robert Pilarski, Matthew B Yurgelun, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Judy E Garber,[...]. J Natl Compr Canc Netw 2020
93
50


Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, Michael Berry, Saundra S Buys, Beth Crawford, Meagan Farmer, Susan Friedman, Judy E Garber, Seema Khan,[...]. J Natl Compr Canc Netw 2016
111
50


Cancer genomics and inherited risk.
Zsofia K Stadler, Kasmintan A Schrader, Joseph Vijai, Mark E Robson, Kenneth Offit. J Clin Oncol 2014
86
50

An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Carolyn Piccinin, Seema Panchal, Nicholas Watkins, Raymond H Kim. Expert Rev Anticancer Ther 2019
8
50

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
50

Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force.
Stephanie A Cohen, Monica L Marvin, Bronson D Riley, Hetal S Vig, Julie A Rousseau, Shanna L Gustafson. J Genet Couns 2013
74
50

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
240
50

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.
Eric R Manahan, Henry M Kuerer, Molly Sebastian, Kevin S Hughes, Judy C Boughey, David M Euhus, Susan K Boolbol, Walton A Taylor. Ann Surg Oncol 2019
52
50

Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.
Angela Hamblin, Sarah Wordsworth, Jilles M Fermont, Suzanne Page, Kulvinder Kaur, Carme Camps, Pamela Kaisaki, Avinash Gupta, Denis Talbot, Mark Middleton,[...]. PLoS Med 2017
48
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.